Kendall E. Donaldson, MD, MS and Christopher E. Starr, MD, highlight best practices when treating neurotrophic keratitis, including differential diagnosis, corneal sensitivity testing, the new classification system, treatments options for each stage, and pipeline therapies.

This activity is supported by an unrestricted educational grant from Dompé.

Click here to view the webinar event, which includes images from the talk.  

Check out the central hub of this webinar series.

Want to register with Evolve Medical Education? Click here.

Drs. Donaldson and Starr delve into cenegermin’s clinical trial data and whether or not it should be used in patients with stage 1 neurotrophic keratitis (NK). They also discuss a handful of investigational agents for treating NK.

This activity is supported by an unrestricted educational grant from Dompé.

Click here to view the webinar event, which includes images from the talk.  

Check out the central hub of this webinar series.

Want to register with Evolve Medical Education? Click here.

Kendall E. Donaldson, MD, MS and Christopher E. Starr, MD, discuss why it’s important to treat stage 1 neurotrophic keratitis, the treatment options for each stage, and a patient who was treated with multiple therapies.

This activity is supported by an unrestricted educational grant from Dompé.

Click here to view the webinar event, which includes images from the talk.  

Check out the central hub of this webinar series.

Want to register with Evolve Medical Education? Click here.

Jessica Steen, OD, FAAO, discusses data from the Score2 clinical trial as well as four cases that highlight how patients with RVOs with macular edema require long-term treatment from a multispeciality team.

This activity is supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc.

Click here Dr. Steen's webinar event, which includes images from the talk.

Check out the central hub of this webinar series.

Want to register with Evolve Medical Education? Click here.

In this insightful microlearning podcast, Dr. Kim Cockerham explores the impact of TED on patients' quality of life, outlines essential questions for diagnosis, and describes a compelling case of inflammatory TED that recurred following orbital decompression surgery and presented with diplopia.

This activity is supported by an unrestricted educational grant from Horizon Therapeutics.

Click here to view the webinar event, which includes images from the talk.

Check out the central hub of this webinar series.

Want to register with Evolve Medical Education? Click here.

Join Amina Malik, MD, as she describes the common signs and symptoms of TED and offers valuable insights into successfully treating and comanaging a case of moderate-to-severe TED.

This activity is supported by an unrestricted educational grant from Horizon Therapeutics.

Click here to view the webinar event, which includes images from the talk.

Check out the central hub of this webinar series.

Want to register with Evolve Medical Education? Click here.

In this informative episode, Dr. Amina Malik navigates the different classification systems for TED severity and inflammatory activity, explores the treatment options for varying severity of disease, and concludes with a case study highlighting the successful use of biologic therapy in managing chronic TED.

This activity is supported by an unrestricted educational grant from Horizon Therapeutics.

Click here to view the webinar event, which includes images from the talk.

Check out the central hub of this webinar series.

Want to register with Evolve Medical Education? Click here.

Kim Cockerham, MD, FACS, explains the challenges of diagnosing TED and recounts a case of advanced TED, which involved a patient who had previously been misdiagnosed with dry eye and ocular hypertension/glaucoma by six other eye care providers, and was eventually successfully treated with teprotumumab.

This activity is supported by an unrestricted educational grant from Horizon Therapeutics.

Click here to view the webinar event, which includes images from the talk.

Check out the central hub of this webinar series.

Want to register with Evolve Medical Education? Click here.

Classification of neurotrophic keratitis is moving away from the Mackie system. Drs. Nichols and Whitley highlight the Neurotrophic Keratitis Study Group classification system and explain the clinical features of each stage.

This activity is supported by an unrestricted educational grant from Dompé.

Click here to view the webinar event, which includes images from the talk.  

Check out the central hub of this webinar series.

Want to register with Evolve Medical Education? Click here.

Kelly K. Nichols, OD, MPH, PhD and Walter O. Whitley, OD, MBA, FAAO, explain why it’s important to perform corneal sensitivity testing on patients suspected of having neurotrophic keratitis and provide tips on best practices. 

This activity is supported by an unrestricted educational grant from Dompé.

Click here to view the webinar event, which includes images from the talk.  

Check out the central hub of this webinar series.

Want to register with Evolve Medical Education? Click here.